SEARCH

SEARCH BY CITATION

References

  • 1
    Gimson AE, Braude S, Mellon PJ, Canalese J, Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet 1982; 25;2: 681-683.
  • 2
    O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186-1192.
  • 3
    Berk PD, Goldberg JD. Charcoal hemoperfusion. Plus ca change, plus c'est la meme chase. Gastroenterology 1988; 94: 1228-1230.
  • 4
    Bihari D. On the demise of the artificial liver. Gastroenterology 1989; 96: 551-552.
  • 5
    Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support for acute and acute-on-chronic liver failure: a systematic review. JAMA 2003; 289: 217-222.
  • 6
    O'Grady JG, Alexander GJ, Hallyar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-445.
  • 7
    Demetriou AA, Brown RS, Busuttil RW, Fair J, McGuire BM, Rosenthal P et al. Prospective, randomised, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239: 660-670.
  • 8
    Watanabe FD, Mullon CJ-P, Hewitt WR, Arkadopoulos N; Kahaku E; Eguchi S, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. Ann Surg 1997; 225: 484-494.